ABSTRACT
The authors present their experience with the dynamic fetoplacental unit function test using a commercial product containing dehydroepiandrosterone sulfate. The recent literature is cited and the results are discussed. Emphasis is placed on the practicability and applicability of the method in connection with a continuous, reliable evaluation of "at risk" pregnancy.
Subject(s)
Dehydroepiandrosterone , Placental Function Tests/methods , Adrenal Cortex Hormones/metabolism , Estriol/blood , Female , Humans , PregnancyABSTRACT
Association of serum alphafetoprotein (alpha FP), human chorionic gonadotropin beta-subunit (beta-HCG), carcinoembryonic antigen (CEA) and ferritin (FER) was studied in a group of 72 patients with epithelial ovarian cancer 15 days after surgery and at various times during 2 years. Only CEA and ferritin are able to reflect tumor burden in detecting evolutive disease; alpha FP and beta-HCG have a diagnostic significance in few cases, probably related to a particular, not evident, histological component of the tumor. Nevertheless the data indicate that the use of marker association can improve our capacity to detect, overall in the residual and evolutive disease, the real clinical burden of the patients.
Subject(s)
Carcinoembryonic Antigen/analysis , Chorionic Gonadotropin/blood , Ferritins/blood , Ovarian Neoplasms/diagnosis , Peptide Fragments/blood , alpha-Fetoproteins/analysis , Adenocarcinoma/diagnosis , Adenocarcinoma, Mucinous/diagnosis , Adult , Aged , Chorionic Gonadotropin, beta Subunit, Human , Cystadenocarcinoma/diagnosis , Endometriosis/diagnosis , Female , Follow-Up Studies , Humans , Mesonephroma/diagnosis , Middle Aged , Ovarian Neoplasms/therapyABSTRACT
Seriated ferritin assays were carried out on 95 patients affected by primitive ovarian epithelial tumour over a period of three years (1979/82), by radioimmunometric assay for human spleen ferritin. Ferritin was elevated in endometrioid tumours and in the presence of active progressing disease and chemotherapy did not influence these values. The ferritin/sideremia ratio was high in the case with pathological levels. Studying the glicosilation of this protein a significant amount of ferritin was not bound to concavallin A, suggesting direct release of this protein by tumour cells.
Subject(s)
Ferritins/blood , Ovarian Neoplasms/blood , Adenocarcinoma/blood , Adenocarcinoma, Mucinous/blood , Carcinoma/blood , Endometriosis/blood , Female , Follow-Up Studies , Humans , Iron/blood , Mesonephroma/blood , Neoplasm Staging , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/surgery , RadioimmunoassayABSTRACT
PIP: The authors examined the incidence of pelvic inflammatory disease (PID) in women using an IUD among the population of an area served by a public health service for family planning. Among 300 women who used the IUD for at least 12 months, 7 cases (2.3%) showed a pelvic infection and 10 patients (3.3%) only a slight salpingitis without other symptoms. The incidence of PID in women using an IUD is about 3-4% and it increases in nulligravidae, in those subjects who engage in frequent intercourse, and in those women who have previously suffered from gonococcal infection. The IUDs are associated with a low incidence of pelvic infection, in most cases slight, so that the use of an IUD does not involve a significant risk of infection. (author's)^ieng
